| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $266.8M | +3.9% |
| R&D Expense | $44.3M | +6.3% |
| SG&A Expense | $44.1M | +11.9% |
| Operating Income | $12.4M | +54.5% |
| Pre-tax Income | $15.6M | +100.7% |
| Income Tax | $3.5M | +81.9% |
| Net Income | $12.1M | +106.9% |
| EPS (Basic) | $0.39 | +105.3% |
| EPS (Diluted) | $0.39 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $46.0M | -1.9% |
| Accounts Receivable | $36.7M | +21.2% |
| Current Assets | $114.4M | +7.0% |
| Total Assets | $497.7M | +2.3% |
| Current Liabilities | $117.2M | +16.8% |
| Stockholders' Equity | $334.1M | -1.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $51.2M | +20.8% |
| Capital Expenditures | $1.8M | -48.3% |
| Investing Cash Flow | -$28.4M | -10.4% |
| Financing Cash Flow | -$23.7M | -281.7% |
| Free Cash Flow | $49.4M | +26.8% |
| +116.7% |